SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-007731
Filing Date
2021-01-13
Accepted
2021-01-13 07:12:32
Documents
19
Period of Report
2021-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d101193d8k.htm   iXBRL 8-K 50302
2 EX-1.1 d101193dex11.htm EX-1.1 174524
3 EX-3.1 d101193dex31.htm EX-3.1 74594
4 EX-5.1 d101193dex51.htm EX-5.1 6899
5 EX-99.1 d101193dex991.htm EX-99.1 27697
9 GRAPHIC g101193g15z14.jpg GRAPHIC 4921
10 GRAPHIC g101193g20o56.jpg GRAPHIC 2505
11 GRAPHIC g101193g60s15.jpg GRAPHIC 11804
  Complete submission text file 0001193125-21-007731.txt   570258

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20210112.xsd EX-101.SCH 3063
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210112_lab.xml EX-101.LAB 18124
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210112_pre.xml EX-101.PRE 11400
12 EXTRACTED XBRL INSTANCE DOCUMENT d101193d8k_htm.xml XML 3493
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 21525058
SIC: 2836 Biological Products, (No Diagnostic Substances)